Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SELP | P16109 | 2/20 | 0.71 |
| ▸ | SELL | P14151 | 1/20 | 0.71 |
| ▸ | SELE | P16581 | 5/20 | 0.64 |
| ▸ | MAG | P20916 | 6/20 | 0.61 |
| ▸ | SIGLEC7 | Q9Y286 | 6/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29466129 | 0.99 | SELP (0.70) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL29466139 | 0.99 | SELP (0.70) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL29391699 | 0.99 | SELP (0.73) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL29372449 | 0.99 | SELP (0.73) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL29448496 | 0.99 | SELP (0.73) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL29389517 | 0.99 | SELP (0.73) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL13195877 | 0.99 | SELP (0.73) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL29405702 | 0.99 | SELP (0.73) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL13978771 | 0.99 | SELP (0.73) | SELPSELLSELEMAGSIGLEC7 | |
| SCHEMBL31010809 | 0.97 | SELP (0.71) | SELPSELLSELEMAGSIGLEC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260004881-A1 | METHODS AND SYSTEMS FOR CHARACTERIZING PROTEINS | NAUTILUS SUBSIDIARY INC (US) | 2026-01-01 | — | — | US | disclosed |
| US-20250292870-A1 | METHODS AND SYSTEMS FOR PROTEIN IDENTIFICATION | NAUTILUS SUBSIDIARY INC (US) | 2025-09-18 | — | — | US | disclosed |
| EP-3701066-B1 | METHODS AND SYSTEMS FOR PROTEIN IDENTIFICATION | NAUTILUS SUBSIDIARY INC (US) | 2024-10-16 | — | — | EP | disclosed |
| EP-4372383-A2 | METHODS AND SYSTEMS FOR PROTEIN IDENTIFICATION | Nautilus Subsidiary, Inc. (US) | 2024-05-22 | — | — | EP | disclosed |
| US-11721412-B2 | Methods for identifying a protein in a sample of unknown proteins | NAUTILUS SUBSIDIARY, INC. (US) | 2023-08-08 | — | — | US | disclosed |
| US-11545234-B2 | Decoding approaches for protein identification | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2023-01-03 | — | — | US | disclosed |
| US-11282586-B2 | Decoding approaches for protein identification | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| US-11282585-B2 | Decoding approaches for protein identification | NAUTILUS BIOTECHNOLOGY, INC. (US) | 2022-03-22 | — | — | US | disclosed |
| US-20220068431-A1 | DECODING APPROACHES FOR PROTEIN IDENTIFICATION | NAUTILUS SUBSIDIARY, INC. | 2022-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260004881-A1 | METHODS AND SYSTEMS FOR CHARACTERIZING PROTEINS | PTMS, SRMS, CHAMP1 | SELP 105/4885SELL 893/4885SELE 874/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.